Knockdown of Nrf2 Inhibits the Angiogenesis of Rat Cardiac Micro-vascular Endothelial Cells under Hypoxic Conditions
Authors:
- Jian FengJFJian Feng
- Guoxiang HeGHGuoxiang He
- Tao JingTJTao Jing
Open Access
- 1 January 2013
- journal article
- Published by Ivyspring International Publisher in International Journal of Biological Sciences
- Vol. 9 (7) , 656-665
Abstract
Angiogenesis plays an important role in myocardial repair after myocardial infarction (MI). Cardiac micro-vascular endothelial cells (CMECs) are important participants in myocardial angiogenesis processes. Recent studies have revealed that Nuclear factor-erythroid 2-related factor 2 (Nrf2), a master transcription factor of endogenous anti-oxidative defense systems, exerts cardio-protection in the cardiovascular system. However, the role of Nrf2 in the process of myocardial angiogenesis and corresponding mechanisms are not fully understood. Thus, the present study investigated the role of Nrf2 in the angiogenesis of rat CMECs to hypoxia. Trans-well assay, three-dimensional Matrigel assay were used to determine cell migration and vascular tube formation. Real-time RT-PCR, ELISA and Western blot were measured mRNA and protein expression. Here, we report that the mRNA and protein expression of Nrf2 and heme oxygenase-1(HO-1) were temporarily upregulated under hypoxic condition. Furthermore, knock down of Nrf2 significantly suppressed the migration and vascular tube formation of rat CMECs to hypoxia, Nrf2 knockdown also significantly decreased HO-1 and vascular endothelial growth factor (VEGF) expression at 48 h after transfection under hypoxic condition. Finally, transfection of CMECs with the Nrf2 over-expressing lentiviral vector upregulated HO-1 expression with a concomitant increase in cell migration and vascular tube formation induced by hypoxia, and this effect was greatly attenuated in the presence of ZnPP (a HO-1 inhibitor). Taken together, these results suggest that Nrf2 may mediate the angiogenesis of CMECs under hypoxic condition, and HO-1 is involved in regulating the angiogenesis of CMECs through Nrf2. Therefore, Nrf2 is a potent regulator of hypoxia-condition mediated angiogenesis in CMECs, which may provide a therapeutic strategy for myocardial repair after MI.Keywords
This publication has 31 references indexed in Scilit:
- Haeme oxygenase promotes progenitor cell mobilization, neovascularization, and functional recovery after critical hindlimb ischaemia in miceCardiovascular Research, 2007
- Biomechanical Forces in Atherosclerosis-Resistant Vascular Regions Regulate Endothelial Redox Balance via Phosphoinositol 3-Kinase/Akt-Dependent Activation of Nrf2Circulation Research, 2007
- Cell Survival Responses to Environmental Stresses Via the Keap1-Nrf2-ARE PathwayAnnual Review of Pharmacology and Toxicology, 2007
- Vascular Endothelial Growth Factor: Basic Science and Clinical ProgressEndocrine Reviews, 2004
- Role of collateral circulation in the acute phase of ST-segment-elevation myocardial infarction treated with primary coronary interventionEuropean Heart Journal, 2004
- Therapeutic angiogenesis for heart failureNature Medicine, 1999
- Molecular mechanisms of blood vessel formationTrends in Biochemical Sciences, 1997
- Cardiac endothelium and tissue growthProgress in Cardiovascular Diseases, 1997
- A New Simple Method for Isolation of Microvascular Endothelial Cells Avoiding Both Chemical and Mechanical InjuriesMicrovascular Research, 1995
- Isolation and characterization of human and rat cardiac microvascular endothelial cellsAmerican Journal of Physiology-Heart and Circulatory Physiology, 1993